Skip to main content
Clinical Trials/NL-OMON19880
NL-OMON19880
Recruiting
N/A

A prospective study on the cardio-metabolic effects of apremilast in patients with psoriatic arthritis

Reade, outpatient rheumatology clinic0 sites50 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Psoriatic arthritis (PsA)
Sponsor
Reade, outpatient rheumatology clinic
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Reade, outpatient rheumatology clinic

Eligibility Criteria

Inclusion Criteria

  • Adult (≥18 years) patients with active PsA
  • \- Indication to start with apremilast (Otezla)

Exclusion Criteria

  • \- Inability or unwillingness to sign informed consent
  • \- Contraindication for apremilast (i.e. pregnancy and hypersensitivity to apremilast and/or its excipients)

Outcomes

Primary Outcomes

Not specified

Similar Trials